Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

32.06
-0.2300-0.71%
Post-market: 32.420.3580+1.12%18:39 EDT
Volume:1.93M
Turnover:61.70M
Market Cap:5.92B
PE:-18.00
High:32.34
Open:32.13
Low:31.55
Close:32.29
52wk High:51.77
52wk Low:27.34
Shares:184.57M
Float Shares:81.38M
Volume Ratio:1.61
T/O Rate:2.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7807
EPS(LYR):-0.9681
ROE:-29.65%
ROA:-7.81%
PB:5.71
PE(LYR):-33.11

Loading ...

Legend Biotech’s Strategic Positioning and Growth Potential: Overcoming Supply Constraints and Sustaining Leadership in the BCMA CAR T Space

TIPRANKS
·
Oct 03

With Stock Down 25% in Two Months, Could Secondary Listing Be the Solution for Legend Biotech (LEGN.US) Price Recovery?

Stock News
·
Sep 21

RBC Capital Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Sep 12

IPO News | Legend Biotech (LEGN.US) Reportedly Considering Second Listing Outside US, Hong Kong Among Potential Locations

Stock News
·
Sep 08

Market Chatter: Legend Biotech Said to Consider Second Listing Outside US

MT Newswires Live
·
Sep 05

MEDIA-Legend Biotech is said to explore second listing outside of US - Bloomberg News

Reuters
·
Sep 05

Legend Biotech Said to Consider Second Listing Outside US, Bloomberg Reports

MT Newswires Live
·
Sep 05

Legend Biotech Coverage Assumed by Cantor Fitzgerald at Overweight

Dow Jones
·
Aug 27

Legend Biotech Corporation to Participate in Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 26

Legend Biotech Is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 25

U.S. RESEARCH ROUNDUP-Amgen, Figma, Nordson

Reuters
·
Aug 25

Legend Biotech Corp : JP Morgan Raises Target Price to $78.00 From $77.00

THOMSON REUTERS
·
Aug 25

Legend Biotech Corp - Carlos Santos Assumes CFO Role From Jessie Yeung

THOMSON REUTERS
·
Aug 18

Press Release: Legend Biotech Appoints Carlos Santos as Chief Financial Officer

Dow Jones
·
Aug 18

Legend Biotech Is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 12

RBC Capital Adjusts Price Target on Legend Biotech to $77 From $75, Maintains Outperform Rating

MT Newswires Live
·
Aug 12

Sector Update: Health Care Stocks Rise Premarket Monday

MT Newswires Live
·
Aug 11

Legend Biotech Reports Q2 2025 Results: Adjusted Net Income of $10.1M, Collaboration Revenue Soars to $219.7M

Reuters
·
Aug 11

Legend Biotech Q2 EPS $(0.34) Misses $(0.14) Estimate, Sales $255.058M Beat $234.236M Estimate

Benzinga
·
Aug 11

Legend Biotech Corporation Q2 Net Income USD -125.38 Million

THOMSON REUTERS
·
Aug 11